Supernus Pharmaceuticals SUPN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$2.29M+80.6% | -$4.11M-127% | -$45.12M-217% | $22.5M+13.0% | -$11.83M-9,638% | ||
| $26.13M+28.2% | $25.02M+32.7% | $24.81M+23.4% | $21.36M+3.1% | $20.38M-1.8% | ||
| $8.48M+5.1% | $9.65M+26.5% | $7.83M+2.0% | $7.51M+14.6% | $8.07M+36.8% | ||
| $66.52M+117% | $19.86M-55.3% | —— | $58.54M+64.3% | $30.6M-20.3% | ||
| $0-100% | $427K+100% | $129K-35.5% | $455K+611% | $327K+31.9% | ||
| -$19.22M-151% | —— | $48.71M+163% | —— | $37.32M+172% | ||
| $9.12M+143% | $8.53M+44.8% | $21.07M+585% | $935K-43.6% | -$21.4M-1,463% | ||
| $56.42M+21.3% | —— | $8.11M+140% | $28.86M+355% | $46.52M+499% | ||
| $66.52M+120% | $19.43M-56.0% | —— | $58.08M+63.3% | $30.27M-20.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Supernus Pharmaceuticals generate?
- Supernus Pharmaceuticals (SUPN) generated $175.5M in operating cash flow over the trailing twelve months.
- What is Supernus Pharmaceuticals's free cash flow?
- After $1.0M of capital expenditures, Supernus Pharmaceuticals's free cash flow was $174.3M over the trailing twelve months, up 1.8% year over year.
- Where does Supernus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
